KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $2.0 million.

  • Quest Diagnostics' Gains from Investment Securities rose 13333.33% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 million, marking a year-over-year increase of 27391.3%. This contributed to the annual value of -$41.0 million for FY2024, which is 19761.9% down from last year.
  • Latest data reveals that Quest Diagnostics reported Gains from Investment Securities of $2.0 million as of Q3 2025, which was up 13333.33% from $42.0 million recorded in Q1 2025.
  • Quest Diagnostics' Gains from Investment Securities' 5-year high stood at $42.0 million during Q1 2025, with a 5-year trough of -$60.0 million in Q2 2022.
  • In the last 5 years, Quest Diagnostics' Gains from Investment Securities had a median value of $2.0 million in 2024 and averaged $2.1 million.
  • As far as peak fluctuations go, Quest Diagnostics' Gains from Investment Securities crashed by 610000.0% in 2022, and later skyrocketed by 22727.27% in 2025.
  • Over the past 5 years, Quest Diagnostics' Gains from Investment Securities (Quarter) stood at $6.0 million in 2021, then plummeted by 583.33% to -$29.0 million in 2022, then soared by 148.28% to $14.0 million in 2023, then plummeted by 128.57% to -$4.0 million in 2024, then surged by 150.0% to $2.0 million in 2025.
  • Its Gains from Investment Securities stands at $2.0 million for Q3 2025, versus $42.0 million for Q1 2025 and -$4.0 million for Q4 2024.